Drug Makers Accused By Vietnam Agency Of Colluding On Prices
This article was originally published in PharmAsia News
Vietnamese officials have accused domestic and foreign drug makers of colluding to fix the price of drugs at a price 200 to 300 times their cost. Representatives of the Competition Control Agency, an arm of the Ministry of Industry and Trade, said pharmaceutical companies, distributors and brokers set the price of drugs before they are imported into Vietnam. Distributors and importers in Vietnam say their prices are determined by the price set by foreign drug makers. The agency said firms also control the volume of drugs on the market so they can keep their prices high. (Click here for more
You may also be interested in...
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.